BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Ribavirin
1
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
9/21/2020 4:02:08 PM | Browse: 168 | Download: 242
2
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature
5/6/2019 10:43:10 AM | Browse: 402 | Download: 521
3
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 691 | Download: 755
4
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM | Browse: 530 | Download: 624
5
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
5/17/2017 6:29:40 AM | Browse: 876 | Download: 854
6
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM | Browse: 579 | Download: 979
7
Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin
1/22/2017 8:28:00 AM | Browse: 821 | Download: 1038
8
Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country
11/18/2016 3:13:00 PM | Browse: 625 | Download: 1102
9
Retrospective study of the associations between hepatitis C virus infection and metabolic factors
10/25/2016 8:46:00 AM | Browse: 838 | Download: 1108
10
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
10/12/2016 2:18:00 PM | Browse: 710 | Download: 564
11
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
8/3/2016 8:11:00 AM | Browse: 807 | Download: 940
12
Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
3/2/2016 1:35:00 PM | Browse: 1065 | Download: 1600
13
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
2/25/2016 7:04:00 PM | Browse: 694 | Download: 952
14
Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
2/22/2016 3:38:00 PM | Browse: 680 | Download: 1056
15
Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-/ribavirin therapy
1/23/2016 5:08:00 PM | Browse: 852 | Download: 743
16
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C
1/20/2016 5:04:00 PM | Browse: 659 | Download: 782
17
Ribavirin: Past, present and future
1/15/2016 9:49:00 AM | Browse: 924 | Download: 778
18
Hepatitis E virus infection in the liver transplant recipients: Clinical presentation and management
1/15/2016 9:49:00 AM | Browse: 663 | Download: 643
19
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 821 | Download: 1332
20
Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients
12/2/2015 12:20:00 PM | Browse: 1043 | Download: 965
21
Hepatitis C in hemodialysis patients
12/2/2015 12:01:00 PM | Browse: 684 | Download: 696
22
Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
11/27/2015 5:17:00 PM | Browse: 845 | Download: 1222
23
Hepatitis E virus infection: Epidemiology and treatment implications
11/12/2015 5:09:00 PM | Browse: 669 | Download: 939
24
Ribavirin contributes to eradicate hepatitis C virus through polarization of T helper 1/2 cell balance into T helper 1 dominance
11/9/2015 6:35:00 PM | Browse: 841 | Download: 771
25
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
6/29/2015 4:40:00 PM | Browse: 803 | Download: 1080
26
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 663 | Download: 1062
27
Natural interferon-beta treatment for patients with chronic hepatitis C in Japan
5/19/2015 5:28:00 PM | Browse: 813 | Download: 855
28
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study
5/18/2015 5:02:00 PM | Browse: 815 | Download: 830
29
Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection
5/18/2015 5:02:00 PM | Browse: 562 | Download: 643
30
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM | Browse: 801 | Download: 1011
31
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM | Browse: 806 | Download: 867
32
Chronic hepatitis C genotype 1 treatment roadmap for resource constrained settings
2/11/2015 5:56:00 PM | Browse: 961 | Download: 1097
33
Retreatment with peginterferon and ribavirin in chronic hepatitis C
2/11/2015 5:56:00 PM | Browse: 652 | Download: 738
34
Study of pruritus in chronic hepatitis C patients
12/20/2014 9:24:00 PM | Browse: 722 | Download: 787
35
Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection
12/5/2014 11:43:00 AM | Browse: 739 | Download: 807
36
New treatments for chronic hepatitis C: an overview for paediatricians
12/5/2014 11:43:00 AM | Browse: 936 | Download: 1005
37
Telaprevir/boceprevir era: From bench to bed and back
9/16/2014 8:07:00 PM | Browse: 978 | Download: 807
38
Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients
9/16/2014 4:56:00 PM | Browse: 668 | Download: 301
39
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
9/16/2014 3:23:00 PM | Browse: 602 | Download: 480
40
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation
9/15/2014 8:53:00 PM | Browse: 811 | Download: 692
41
Hepatitis C, stigma and cure
9/12/2014 8:41:00 PM | Browse: 764 | Download: 482
42
Hepatitis C genotype 6: A concise review and response-guided therapy proposal
9/10/2014 4:40:00 PM | Browse: 732 | Download: 561
43
Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy
9/5/2014 2:19:00 PM | Browse: 609 | Download: 534
44
Challenges in managing hepatitis C virus infection in cancer patients
9/1/2014 2:51:00 PM | Browse: 611 | Download: 381
45
Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection
9/1/2014 2:51:00 PM | Browse: 733 | Download: 634
46
Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
8/28/2014 5:50:00 PM | Browse: 1011 | Download: 585
47
Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
8/26/2014 3:10:00 PM | Browse: 788 | Download: 591
48
Emerging therapeutic options for the management of hepatitis C infection
8/26/2014 2:46:00 PM | Browse: 625 | Download: 441
49
Ns3 protease inhibitors for treatment of chronic hepatitis C virus infection: Efficacy and safety
8/26/2014 2:23:00 PM | Browse: 641 | Download: 787